Lilly's Foundayo Clocks 1,390 Prescriptions in Debut Week as Oral Obesity Drug Race Heats Up Written By sheeba farhat19 April 2026 12:09 PM ISTNew Delhi: Eli Lilly's newly launched weight-loss pill was prescribed 1,390 ‌times in the U.S. in its first week of sales, according to analysts who...
No Ads for Prescription Drugs: Panel Flags Surrogate Advertising, Misleading Promotions of GLP-1 Obesity Drugs Written By Susmita Roy18 April 2026 8:51 PM ISTNew Delhi: The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against...
USFDA Flags Liver Safety Concerns, Asks Eli Lilly for Additional Data on Obesity Pill Foundayo Written By sheeba farhat15 April 2026 7:35 PM ISTNew Delhi: The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved ​obesity pill,...
Wegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US Market Written By MD Bureau8 April 2026 7:10 PM ISTBengaluru: Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United...
Emcure Pharma Cuts Poviztra Price by 55%, Starting Dose Now Rs 3,999 per Month Written By Parthika Patel4 April 2026 2:25 PM ISTNew Delhi: Emcure Pharmaceuticals Limited has announced a major price reduction of up to 55% for the starting dose of its weight management drug...
USFDA Approves Higher-Dose Wegovy to Boost Weight Loss Outcomes Written By sheeba farhat21 March 2026 11:00 AM ISTWashington: Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more...
Eli Lilly to Invest USD 3 Billion in China to Boost Production of Diabetes, Obesity Drug Orforglipron Written By sheeba farhat12 March 2026 10:00 AM ISTShanghai: Eli Lilly plans to invest USD 3 billion over the next decade to expand supply chain capacity in China and build production capacity for its...
Weight Regain Common After Stopping Weight Management Medications: Meta-Analysis Finds Written By Aashi verma18 Feb 2026 9:15 PM ISTUK: A recent systematic review and meta-analysis reveals that discontinuing weight management medications (WMMs) leads to an average monthly weight...
Natco Pharma Gets Court Nod to Make, Export Semaglutide for Diabetes and Obesity Markets Written By Susmita Roy10 Feb 2026 7:32 PM ISTNew Delhi: Natco Pharma has secured regulatory clearance from the High Court to manufacture semaglutide and export the drug to select international...
Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India Written By Parthika Patel5 Feb 2026 10:31 PM ISTNew Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo...
Roche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial Written By sheeba farhat28 Jan 2026 4:46 PM ISTRoche's experimental obesity drug CT-388 reduces appetite and is in the same class as Lilly's market-leading Zepbound, also known as tirzepatide and...
Cipla Emerges as Domestic Contender in Anti-Obesity Market with Yurpeak Written By Susmita Roy10 Jan 2026 10:06 PM ISTNew Delhi: India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 agonist brand...
